The multidrug transporter ABCG2: still more questions than answers

Article English OPEN
Horsey, Aaron J. ; Cox, Megan H. ; Sarwat, Sunehera ; Kerr, Ian D. (2016)
  • Publisher: Portland Press Ltd
  • Journal: Biochemical Society Transactions (issn: 0300-5127, vol: 44, pp: 824-830)
  • Related identifiers: pmc: PMC4900755, doi: 10.1042/BST20160014
  • Subject: 46 | 24 | ABCG2 | ATPase | 4 | ABC transporter | Membrane Proteins From A to Z | multidrug pump | pharmacology | Biochemical Society Focused Meetings
    mesheuropmc: sense organs | animal structures | embryonic structures

ABCG2 is one of at least three human ATP binding cassette (ABC) transporters which can facilitate the export from cells of a wide range of chemically unrelated drug molecules. This capacity for multidrug transport is not only a confounding factor in chemotherapy, but is also one of the more perplexing phenomena in transporter biochemistry. Since its discovery in the last decade of the 20th century much has been revealed about ABCG2’s localization, physiological function and its broad substrate range. There have also been many investigations of its structure and molecular mechanism. In this mini review article we take a Rumsfeldian approach to ABCG2 and essentially ask what we do know about this transporter, and what we will need to know about this transporter if we wish to use modulation of ABCG2 activity as a therapeutic approach.
  • References (66)
    66 references, page 1 of 7

    1 Wong, K., Ma, J., Rothnie, A., Biggin, P.C. and Kerr, I.D. (2014) Towards understanding promiscuity in multidrug efflux pumps. Trends Biochem. Sci. 39, 8-16 CrossRef PubMed

    2 Mao, Q. and Unadkat, J.D. (2015) Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport - an update. AAPS J. 17, 65-82 CrossRef PubMed

    3 Darby, R.A., Callaghan, R. and McMahon, R.M. (2011) P-glycoprotein inhibition; the past, the present and the future. Curr. Drug Metab. 12, 722-731 CrossRef PubMed

    4 Jonker, J.W., Buitelaar, M., Wagenaar, E., Van Der Valk, M.A., Scheffer, G.L., Scheper, R.J., Plosch, T., Kuipers, F., Elferink, R.P., Rosing, H. et al. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U.S.A. 99, 15649-15654 CrossRef PubMed

    5 Haider, A.J., Cox, M.H., Jones, N., Goode, A.J., Bridge, K.S., Wong, K., Briggs, D. and Kerr, I.D. (2015) Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences. Biosci. Rep. 35, e00241 CrossRef PubMed

    6 Aronica, E., Gorter, J.A., Redeker, S., van Vliet, E.A., Ramkema, M., Scheffer, G.L., Scheper, R.J., van der Valk, P., Leenstra, S., Baayen, J.C. et al. (2005) Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia 46, 849-857 CrossRef PubMed

    7 Zhang, W., Mojsilovic-Petrovic, J., Andrade, M.F., Zhang, H., Ball, M. and Stanimirovic, D.B. (2003) Expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17, 2085-2087 PubMed

    8 Agarwal, S., Sane, R., Ohlfest, J.R. and Elmquist, W.F. (2011) The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain. J. Pharmacol. Exp. Ther. 336, 223-233 CrossRef PubMed

    9 Bauer, M., Karch, R., Zeitlinger, M., Stanek, J., Philippe, C., Wadsak, W., Mitterhauser, M., Jager, W., Haslacher, H., Muller, M. and Langer, O. (2013) Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier. J. Nucl. Med. 54, 1181-1187 CrossRef PubMed

    10 Gutmann, H., Hruz, P., Zimmermann, C., Beglinger, C. and Drewe, J. (2005) Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem. Pharmacol. 70, 695-699 CrossRef PubMed

  • Metrics
    No metrics available
Share - Bookmark